Amgen Inc. (AMGN) is listed on NASDAQ in Biotech Stocks. It is $432.33, -1.07%, with a $233.7B market cap. RSI is 66.2, near overbought. The latest reported quarter beat estimates. Insiders were net sellers across the listed trades.
Technical Analysis
RSI (14) 66.2 Near Overbought
Market Cap $233.7B
Volume 2.9M
Fundamentals — 10-Q Q2 2026
Revenue $18.7B
Net Income $4.2B
EPS $7.71
Gross Margin 70.2%
Operating Margin 33.1%
Net Margin 22.5%
Debt / Equity 4.9x
P/E Ratio 56.1x
Earnings
Recent Insider Trades
| Name | Title | Type | Shares | Price | Value | Date |
|---|---|---|---|---|---|---|
| Khosla Rachna | SVP, Business Development | Sell | 3,252 | $414.05 | $1.3M | 2026 Aug 13 |
| Miller Derek | SVP, Human Resources | Sell | 3,890 | $402.54 | $1.6M | 2026 Aug 6 |
| Grygiel Nancy A. | SVP & CCO | Sell | 2,970 | $402.16 | $1.2M | 2026 Aug 6 |
| Grygiel Nancy A. | SVP & CCO | Sell | 1,237 | $323.73 | $400,451 | 2026 May 4 |
| Santos Esteban | EVP, Operations | Sell | 54,792 | $379.12 | $20.8M | 2026 Feb 26 |
| Grygiel Nancy A. | SVP & CCO | Sell | 3,139 | $337.26 | $1.1M | 2025 Nov 20 |
| Khosla Rachna | SVP, Business Development | Sell | 890 | $336.24 | $299,254 | 2025 Nov 12 |
| Gordon Murdo | EVP, Global Commercial Ops | Sell | 6,879 | $336.83 | $2.3M | 2025 Nov 12 |
| Grygiel Nancy A. | SVP & CCO | Sell | 1,267 | $296.99 | $376,286 | 2025 Aug 20 |
| Khosla Rachna | SVP, Business Development | Sell | 1,500 | $289.68 | $434,520 | 2025 Jun 5 |
| Busch Matthew C. | VP, Finance & CAO | Sell | 1,000 | $279.69 | $279,690 | 2025 May 2 |
| Reese David M | EVP & Chief Technology Officer | Sell | 33,936 | $301.56 | $10.2M | 2025 Feb 21 |
| Santos Esteban | EVP, Operations | Sell | 8,711 | $292.84 | $2.6M | 2025 Feb 19 |
| Miller Derek | SVP, Human Resources | Sell | 2,024 | $293.45 | $593,940 | 2025 Feb 19 |
| Gordon Murdo | EVP, Global Commercial Ops | Sell | 8,771 | $294.79 | $2.6M | 2025 Feb 11 |
| Graham Jonathan P | EVP & Gen. Counsel & Secy. | Sell | 25,045 | $293.12 | $7.3M | 2025 Feb 7 |
| Grygiel Nancy A. | SVP & CCO | Sell | 1,589 | $304.47 | $483,803 | 2025 Feb 5 |
| Grygiel Nancy A. | SVP & CCO | Sell | 2,117 | $313.09 | $662,812 | 2024 May 3 |
| Grygiel Nancy A. | SVP & CCO | Sell | 2,096 | $273.03 | $572,271 | 2023 Dec 4 |
| Graham Jonathan P | EVP, Gen. Counsel & Secy. | Sell | 10,000 | $272.81 | $2.7M | 2023 Nov 8 |
Other Biotech Stocks
| Ticker | Price | RSI | Mkt Cap |
|---|---|---|---|
| | $137.93 | 63.6 | $55.1B |
| | $145.64 | 60.3 | $180.6B |
| | $208.02 | 55.9 | $44.6B |
| | $1,023.96 | 63.8 | -- |
| | $141.42 | 61.5 | $8.9B |
| | $102.12 | 51.7 | -- |
| | $134.97 | 69.6 | $10.2B |
| | $105.31 | 69.1 | $12.0B |
Take AMGN further
- Browse Biotech Stocks for the rest of the group, with what the businesses in it have in common and where they differ.
- Put AMGN in a portfolio and see what it does to total return, drawdown, and how the rest of your holdings move with it. Compares against the S&P 500 over the same days, free and without an account.
- Screen for others like it by RSI, valuation, market cap, and insider activity.
- Check the earnings calendar for when Amgen Inc. next reports.
Set alerts on AMGN
Get notified when Amgen Inc. hits your price targets or technical conditions are met.
Get Started Free